Presentation TCT 2019 Maximizing CTO PCI Durability (Optimizing Vessel Healing, Avoiding Stent Fractures, Using Adjunctive Technologies Including Drug-Eluting Balloons) Presenter: Paul Knaapen September 28, 2019
News TCT 2019 TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off Shelley Wood September 26, 2019
Presentation TCT 2019 Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT Presenter: Stephan Windecker September 26, 2019
Presentation TCT 2019 Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes! Presenter: David Kandzari September 26, 2019
Presentation TCT 2019 Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance! Presenter: Stephan Windecker September 26, 2019
Presentation TCT 2019 Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years Presenter: Mamas Mamas September 26, 2019
Presentation TCT 2019 TCT 98: Five-Year Clinical Results of Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion Presenter: Lei Song September 25, 2019
Presentation TCT 2019 TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT Presenter: Robert-Jan Van Geuns September 25, 2019
Presentation TCT 2019 TCT 29: Impact of intravascular ultrasound-guided drug-eluting stent implantation on patients with chronic kidney disease: subgroup analysis from ULTIMATE trial Presenter: Junjie Zhang September 25, 2019
Presentation TCT 2019 TCT 44: Impact of Stent Edge Hinging on Chronic Neointimal Hyperplasia after Newer Generation Drug-Eluting Stent Placement in RCA Presenter: Takahiro Jimba September 25, 2019
Presentation TCT 2019 TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial Presenter: Jens Wiebe September 25, 2019
Presentation TCT 2019 Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment Presenter: Binita Shah September 25, 2019
Presentation TCT 2019 Drug-Eluting Stent Platforms and Outcomes 2019 Presenter: Roberto Diletti September 25, 2019
News Conference News ESC 2019 BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI Caitlin E. Cox September 10, 2019
News Conference News ESC 2019 For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI Todd Neale September 03, 2019
News Conference News ESC 2019 Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS Michael O'Riordan September 01, 2019
News Industry News SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent July 23, 2019
News Industry News SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz July 11, 2019
News Conference News TVT 2019 PCI During or After TAVR No Riskier Than PCI Before Valve Replacement Michael O'Riordan June 13, 2019
News Conference News EuroPCR 2019 Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years Michael O'Riordan May 27, 2019